A contribution of VSM-EGFR to obesity- and type 2 diabetes-associated and other vascular alterations [3, 7–11], as well as enhanced vascular EGFR activity during hyperglycaemia with pathophysiological relevance, has been described. The gene discussed is EGFR; the disease is obesity due to melanocortin 4 receptor deficiency.